A Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.

Autor: Strong J; University of Maryland School of Medicine, Baltimore, Maryland, USA., Zhou AE; University of Maryland School of Medicine, Baltimore, Maryland, USA., Alkaabba F; University of Maryland School of Medicine, Baltimore, Maryland, USA., Soldin D; University of Maryland School of Medicine, Baltimore, Maryland, USA., Moon J; University of Maryland School of Medicine, Baltimore, Maryland, USA., Alharthy H; University of Maryland School of Medicine, Baltimore, Maryland, USA., Syed O; University of Maryland School of Medicine, Baltimore, Maryland, USA., Liu Y; University of Maryland School of Medicine, Baltimore, Maryland, USA., Turney K; University of Maryland School of Medicine, Baltimore, Maryland, USA., Markidan J; University of Maryland School of Medicine, Baltimore, Maryland, USA., Malone L; University of Maryland School of Medicine, Baltimore, Maryland, USA., Lee ST; University of Maryland School of Medicine, Baltimore, Maryland, USA., DeRosa P; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jazyk: angličtina
Zdroj: Case reports in dermatology [Case Rep Dermatol] 2022 Nov 07; Vol. 14 (3), pp. 339-343. Date of Electronic Publication: 2022 Nov 07 (Print Publication: 2022).
DOI: 10.1159/000527597
Abstrakt: Sweet syndrome (SS), or acute febrile neutrophilic dermatosis, is a rare painful skin condition that is characterized by hyperpyrexia, peripheral blood and skin neutrophilia, and edematous skin lesions. Necrotizing SS (NSS) is a severe and locally aggressive condition that histopathologically resembles a necrotizing soft tissue infection. As opposed to necrotizing soft tissue infections, NSS responds to systemic steroids. SS is divided into three subtypes: classical SS, malignancy-associated SS, and drug-induced SS. Within the malignancy-associated SS subtype, both solid tumor and hematologic malignancies have been precursors to developing SS. Here, we present a case of acute myeloid leukemia-associated NSS.
Competing Interests: The authors have no conflicts of interest to declare.
(Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje